FDA Approves VENOFER — Fresenius Medical Care Holdings, Inc.

# FDA Approves Fresenius Medical Care's Venofer for Intravenous Iron Supplementation Fresenius Medical Care Holdings, Inc. received FDA approval for Venofer (iron sucrose), an intravenous iron replacement therapy designed to treat iron deficiency anemia in dialysis patients, positioning the company to capture significant market share in the specialized nephrology treatment segment. The approval of this novel intravenous formulation represents a meaningful commercial opportunity for Fresenius in the growing dialysis market, as it offers improved safety and efficacy profiles compared to existing iron supplementation